id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0557-0004,FDA,FDA-2011-N-0557,HHS/OS/ASPR/Biomedical Advanced Research and Development Authority (BARDA) to FDA Division of Dockets Management - Comment re FDA-2011-N-0557-0003,Supporting & Related Material,Reference (internal unless indicated),2012-02-03T05:00:00Z,2012,2,,,2012-02-03T22:11:30Z,,0,0,0900006480f86db5
FDA-2011-N-0557-0002,FDA,FDA-2011-N-0557,Advancing Regulatory Science for Highly Multiplexed Microbiology/Medical Countermeasure Devices; Public Meeting; Reopening of Comment Period,Notice,Extension of Comment Period,2011-11-21T05:00:00Z,2011,11,2011-11-21T05:00:00Z,2011-12-22T04:59:59Z,2012-01-26T22:58:19Z,2011-29937,0,0,0900006480f70972
FDA-2011-N-0557-0001,FDA,FDA-2011-N-0557,Advancing Regulatory Science for Highly Multiplexed Microbiology/ Medical Countermeasure Devices; Public Meeting,Notice,Meeting,2011-08-08T04:00:00Z,2011,8,2011-08-08T04:00:00Z,2011-09-14T03:59:59Z,2012-01-26T22:54:44Z,2011-19996,0,0,0900006480ed9e4f